Dr. Reem Ghalib, MD
Claim this profileTexas Clinical Research Institute, LLC
Studies Non-alcoholic Fatty Liver Disease
Studies Fatty Liver Disease
5 reported clinical trials
8 drugs studied
Area of expertise
1Non-alcoholic Fatty Liver Disease
Stage I
Stage II
2Fatty Liver Disease
Stage I
Stage II
Affiliated Hospitals
Clinical Trials Reem Ghalib, MD is currently running
HM15211
for Non-alcoholic Steatohepatitis (NASH)
This trial is testing a medication called HM15211 to see if it can help people with a liver disease called NASH. The study will check if the medication is safe and effective over a period of time.
Recruiting0 awards Phase 23 criteria
Lanifibranor
for Nonalcoholic Steatohepatitis (NASH)
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
Recruiting1 award Phase 31 criteria
More about Reem Ghalib, MD
Clinical Trial Related4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Reem Ghalib, MD has experience with
- Placebo
- Lanifibranor
- IVA337
- Belapectin
- EDP-305
- HM15211
Breakdown of trials Reem Ghalib, MD has run
Non-alcoholic Fatty Liver Disease
Fatty Liver Disease
Nonalcoholic Steatohepatitis
Type 2 Diabetes
Varicose Veins
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Reem Ghalib, MD specialize in?
Reem Ghalib, MD focuses on Non-alcoholic Fatty Liver Disease and Fatty Liver Disease. In particular, much of their work with Non-alcoholic Fatty Liver Disease has involved Stage I patients, or patients who are Stage II.
Is Reem Ghalib, MD currently recruiting for clinical trials?
Yes, Reem Ghalib, MD is currently recruiting for 2 clinical trials in Arlington Texas. If you're interested in participating, you should apply.
Are there any treatments that Reem Ghalib, MD has studied deeply?
Yes, Reem Ghalib, MD has studied treatments such as Placebo, Lanifibranor, IVA337.
What is the best way to schedule an appointment with Reem Ghalib, MD?
Apply for one of the trials that Reem Ghalib, MD is conducting.
What is the office address of Reem Ghalib, MD?
The office of Reem Ghalib, MD is located at: Texas Clinical Research Institute, LLC, Arlington, Texas 76012 United States. This is the address for their practice at the Texas Clinical Research Institute, LLC.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.